Back to top

messenger-rna: Archive

Zacks Equity Research

Pfizer (PFE), BioNTech Post Data on COVID Jab for Kids Under 5

Pfizer (PFE) and BioNTech (BNTX) report updated data, showing that their three-dose COVID-19 vaccine is 73.2% effective in children under five years.

PFEPositive Net Change MRNAPositive Net Change BNTXPositive Net Change

Zacks Equity Research

Moderna (MRNA) Seeks FDA Nod for Omicron-Based COVID Jab

Moderna's (MRNA) bivalent COVID-19 booster vaccine, mRNA-1273.222, is designed to target the Omicron BA.4 and BA.5 subvariants. The vaccine has been developed specifically for the U.S. market.

PFEPositive Net Change MRNAPositive Net Change BNTXPositive Net Change

Zacks Equity Research

Moderna (MRNA) to Supply Omicron-based COVID Jab in Canada

Moderna's (MRNA) Omicron-specific bivalent vaccine booster is yet to be approved by Canadian health authorities. The government seeks to purchase 12 million doses of the same in 2022.

PFEPositive Net Change MRNAPositive Net Change BNTXPositive Net Change